Submitted URL: https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwia...
Effective URL: https://www.biopharmaapac.com/e-book-mabpurifications?__s=2220yg06mvnswjo9af2o&utm_source=drip&utm_medium=email&utm_campaign=B...
Submission: On February 11 via api from DE — Scanned from DE

Summary

This website contacted 4 IPs in 1 countries across 5 domains to perform 11 HTTP transactions. The main IP is 2606:4700:3037::6815:6025, located in United States and belongs to CLOUDFLARENET, US. The main domain is www.biopharmaapac.com.
TLS certificate: Issued by GTS CA 1P5 on December 30th 2023. Valid for: 3 months.
This is the only time www.biopharmaapac.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 1 3.224.158.31 ()
8 2606:4700:303... 13335 (CLOUDFLAR...)
1 2606:4700::68... 13335 (CLOUDFLAR...)
1 2606:4700::68... 13335 (CLOUDFLAR...)
1 2606:4700::68... 13335 (CLOUDFLAR...)
11 4
Apex Domain
Subdomains
Transfer
8 biopharmaapac.com
www.biopharmaapac.com
biopharmaapac.com
4 MB
1 cloudflareinsights.com
static.cloudflareinsights.com — Cisco Umbrella Rank: 782
7 KB
1 cloudflare.com
cdnjs.cloudflare.com — Cisco Umbrella Rank: 223
28 KB
1 jsdelivr.net
cdn.jsdelivr.net — Cisco Umbrella Rank: 314
22 KB
1 dripemail2.com
t.dripemail2.com — Cisco Umbrella Rank: 183100
206 B
11 5
Domain Requested by
5 biopharmaapac.com www.biopharmaapac.com
3 www.biopharmaapac.com www.biopharmaapac.com
static.cloudflareinsights.com
1 static.cloudflareinsights.com www.biopharmaapac.com
1 cdnjs.cloudflare.com www.biopharmaapac.com
1 cdn.jsdelivr.net www.biopharmaapac.com
1 t.dripemail2.com 1 redirects
11 6

This site contains links to these domains. Also see Links.

Domain
biopharmaapac.com
www.thermofisher.com
Subject Issuer Validity Valid
biopharmaapac.com
GTS CA 1P5
2023-12-30 -
2024-03-29
3 months crt.sh
sni.cloudflaressl.com
Cloudflare Inc ECC CA-3
2023-05-02 -
2024-05-01
a year crt.sh

This page contains 1 frames:

Primary Page: https://www.biopharmaapac.com/e-book-mabpurifications?__s=2220yg06mvnswjo9af2o&utm_source=drip&utm_medium=email&utm_campaign=Biocon+Biologics+Teams+Up+with+Sandoz+Australia+for+Biosimilar+Trastuzumab+and+Bevacizumab
Frame ID: 1CBD16A9E4B8842BA50F254D06F1BB29
Requests: 11 HTTP requests in this frame

Screenshot

Page Title

E-book Mabpurifications

Page URL History Show full URLs

  1. https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6I... HTTP 307
    https://www.biopharmaapac.com/e-book-mabpurifications?__s=2220yg06mvnswjo9af2o&utm_source=drip&utm_medium=... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • <link[^>]* href=[^>]*?bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.css

Overall confidence: 100%
Detected patterns
  • static\.cloudflareinsights\.com/beacon(?:\.min)?\.js

Overall confidence: 100%
Detected patterns
  • /([\d.]+)/jquery(?:\.min)?\.js
  • jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

Overall confidence: 100%
Detected patterns
  • <link [^>]*?href="?[a-zA-Z]*?:?//cdn\.jsdelivr\.net/
  • //cdn\.jsdelivr\.net/

Page Statistics

11
Requests

100 %
HTTPS

80 %
IPv6

5
Domains

6
Subdomains

4
IPs

1
Countries

4494 kB
Transfer

4688 kB
Size

1
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwiaWF0IjoxNzA3NTU2ODg2LCJuYmYiOjE3MDc1NTY4ODYsImFjY291bnRfaWQiOiI2MTU3NjEzIiwiZGVsaXZlcnlfaWQiOiI1dHQ4NWZvYzVkNGdscnFwc2J1aSIsInVybCI6Imh0dHBzOi8vd3d3LmJpb3BoYXJtYWFwYWMuY29tL2UtYm9vay1tYWJwdXJpZmljYXRpb25zP19fcz0yMjIweWcwNm12bnN3am85YWYybyZ1dG1fc291cmNlPWRyaXAmdXRtX21lZGl1bT1lbWFpbCZ1dG1fY2FtcGFpZ249QmlvY29uK0Jpb2xvZ2ljcytUZWFtcytVcCt3aXRoK1NhbmRveitBdXN0cmFsaWErZm9yK0Jpb3NpbWlsYXIrVHJhc3R1enVtYWIrYW5kK0JldmFjaXp1bWFiIn0.KAC39UFtXoGjgVApxYHyizhUcgBqbZbYaoZWxVylHLY HTTP 307
    https://www.biopharmaapac.com/e-book-mabpurifications?__s=2220yg06mvnswjo9af2o&utm_source=drip&utm_medium=email&utm_campaign=Biocon+Biologics+Teams+Up+with+Sandoz+Australia+for+Biosimilar+Trastuzumab+and+Bevacizumab Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

11 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request e-book-mabpurifications
www.biopharmaapac.com/
Redirect Chain
  • https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwiaWF0IjoxNzA3NTU2ODg2LCJuYmYiOjE3MDc1NTY4ODYsImFjY291bnRfaWQiOiI2MTU3NjEzIiwiZ...
  • https://www.biopharmaapac.com/e-book-mabpurifications?__s=2220yg06mvnswjo9af2o&utm_source=drip&utm_medium=email&utm_campaign=Biocon+Biologics+Teams+Up+with+Sandoz+Australia+for+Biosimilar+Trastuzum...
11 KB
4 KB
Document
General
Full URL
https://www.biopharmaapac.com/e-book-mabpurifications?__s=2220yg06mvnswjo9af2o&utm_source=drip&utm_medium=email&utm_campaign=Biocon+Biologics+Teams+Up+with+Sandoz+Australia+for+Biosimilar+Trastuzumab+and+Bevacizumab
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare / PHP/7.0.33
Resource Hash
1b421c79314cbd1c6e72ca4bc447f0479a476448c6beff8f2270e0a35450225a
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

alt-svc
h3=":443"; ma=86400
cache-control
no-cache
cf-cache-status
DYNAMIC
cf-ray
853ce6fedc1a4d7c-FRA
content-encoding
br
content-security-policy
upgrade-insecure-requests
content-type
text/html; charset=UTF-8
date
Sun, 11 Feb 2024 13:22:43 GMT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
platform
hostinger
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=1PvUZ%2BU6GcHsGOFlaxMGv%2FMJn18BNWTizS85Oco9YmyDpWL1YWXb4TuqoLA4aNw8huPcSa52fZu8eUNQdbpNWTTcT9%2BElx%2FLx72%2F5jI8HXVu%2BI1i%2BkIKCJYiBzThLeddky32nQn1lJ5ftS9jHWYz0exhcBI%3D"}],"group":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
x-powered-by
PHP/7.0.33
x-turbo-charged-by
LiteSpeed

Redirect headers

content-length
0
date
Sun, 11 Feb 2024 13:22:43 GMT
location
https://www.biopharmaapac.com/e-book-mabpurifications?__s=2220yg06mvnswjo9af2o&utm_source=drip&utm_medium=email&utm_campaign=Biocon+Biologics+Teams+Up+with+Sandoz+Australia+for+Biosimilar+Trastuzumab+and+Bevacizumab
bootstrap.min.css
cdn.jsdelivr.net/npm/bootstrap@4.0.0/dist/css/
141 KB
22 KB
Stylesheet
General
Full URL
https://cdn.jsdelivr.net/npm/bootstrap@4.0.0/dist/css/bootstrap.min.css
Requested by
Host: www.biopharmaapac.com
URL: https://www.biopharmaapac.com/e-book-mabpurifications?__s=2220yg06mvnswjo9af2o&utm_source=drip&utm_medium=email&utm_campaign=Biocon+Biologics+Teams+Up+with+Sandoz+Australia+for+Biosimilar+Trastuzumab+and+Bevacizumab
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:5814 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
2c0f3dcfe93d7e380c290fe4ab838ed8cadff1596d62697f5444be460d1f876d
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.biopharmaapac.com/
Origin
https://www.biopharmaapac.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Sun, 11 Feb 2024 13:22:44 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-content-type-options
nosniff
cf-cache-status
HIT
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
age
7511790
x-jsd-version
4.0.0
content-encoding
br
x-cache
HIT
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
x-served-by
cache-fra-eddf8230094-FRA
x-jsd-version-type
version
server
cloudflare
etag
W/"235ed-iVElpFIqOxDuetoG7mUDWHy/lcU"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=puGwwWZS9UYFQHWDcfK1YgEpJas8EfSc4mE3vOl01tyBeiYL%2Fu4temzP7o6%2BeBfa5PGwdPZdkyhjquPlvsIUOu5%2F%2BCLz4PyetPSESCpheOxha9X1hjo6muhtZ244ffIQQLcQ57365pnxKhe3q2I%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/css; charset=utf-8
access-control-allow-origin
*
access-control-expose-headers
*
cache-control
public, max-age=31536000, s-maxage=31536000, immutable
timing-allow-origin
*
cf-ray
853ce7010cab90fe-FRA
style.css
biopharmaapac.com/webinar/whitepaper-purificationresin-16-6-2023/css/
3 KB
1 KB
Stylesheet
General
Full URL
https://biopharmaapac.com/webinar/whitepaper-purificationresin-16-6-2023/css/style.css
Requested by
Host: www.biopharmaapac.com
URL: https://www.biopharmaapac.com/e-book-mabpurifications?__s=2220yg06mvnswjo9af2o&utm_source=drip&utm_medium=email&utm_campaign=Biocon+Biologics+Teams+Up+with+Sandoz+Australia+for+Biosimilar+Trastuzumab+and+Bevacizumab
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
475c0c80a58a2870c622a2ab11960c2e44f98008e01d0e22b6ec87a001cdd488
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaapac.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Sun, 11 Feb 2024 13:22:44 GMT
content-security-policy
upgrade-insecure-requests
content-encoding
br
cf-cache-status
HIT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age
426194
alt-svc
h3=":443"; ma=86400
last-modified
Sun, 24 Dec 2023 14:35:38 GMT
server
cloudflare
etag
W/"c12-658841ba-e22d3b0f6c4cdca9;gz"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=6MW%2Fj2JKioT%2BTWoxfGr03QLUgXK5Sj33I1sffevAtwT3UZ3s9v5ykB6uh4G7Jz4nm5VSinbRQRy6yVoEVyt6%2B3zOLaz4BrDfkwgwQon9vSmntGk5NIJ2CSlF9ag%2BfEl7iHEwMn5fqNJdjA2Sl8BNTQ%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/css
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
platform
hostinger
cf-ray
853ce7011f7c4d7c-FRA
expires
Tue, 13 Feb 2024 14:59:30 GMT
ThermoFisher-Logo-Site.png
biopharmaapac.com/webinar/whitepaper-purificationresin-16-6-2023/images/
40 KB
40 KB
Image
General
Full URL
https://biopharmaapac.com/webinar/whitepaper-purificationresin-16-6-2023/images/ThermoFisher-Logo-Site.png
Requested by
Host: www.biopharmaapac.com
URL: https://www.biopharmaapac.com/e-book-mabpurifications?__s=2220yg06mvnswjo9af2o&utm_source=drip&utm_medium=email&utm_campaign=Biocon+Biologics+Teams+Up+with+Sandoz+Australia+for+Biosimilar+Trastuzumab+and+Bevacizumab
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
9a02cba7ed62b5399d8b1091eedaedbb8abdcd651754d7098b1dd9664585839f
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaapac.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Sun, 11 Feb 2024 13:22:44 GMT
content-security-policy
upgrade-insecure-requests
cf-cache-status
HIT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age
426194
alt-svc
h3=":443"; ma=86400
content-length
40935
last-modified
Sun, 24 Dec 2023 14:35:38 GMT
server
cloudflare
etag
"9fe7-658841ba-ba5112ffaca7fc56;;;"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=lqcLNlpMULF9aO698aB8M11JzeYbsrJ5BLx0HfYP8AfHaWzuV4XkhgdH%2F88Pt4iOfAcsn48MS89GPdZBuJs8WjRKWR%2BF82DMA3gvl03KH%2B7iqK6IyyAohq4%2B7MTIREWZ5YefUDVVqFxCb8I%2F8P4biA%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type
image/png
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
cf-ray
853ce7011f8a4d7c-FRA
expires
Tue, 13 Feb 2024 14:59:30 GMT
logo.jpg
biopharmaapac.com/bundles/taai/app/site/images/
39 KB
39 KB
Image
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/images/logo.jpg
Requested by
Host: www.biopharmaapac.com
URL: https://www.biopharmaapac.com/e-book-mabpurifications?__s=2220yg06mvnswjo9af2o&utm_source=drip&utm_medium=email&utm_campaign=Biocon+Biologics+Teams+Up+with+Sandoz+Australia+for+Biosimilar+Trastuzumab+and+Bevacizumab
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
d997981b750d83dcba2e00d81538fec720b77fddf3862399d79beae42ca8659c
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaapac.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Sun, 11 Feb 2024 13:22:44 GMT
content-security-policy
upgrade-insecure-requests
cf-cache-status
HIT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age
197073
alt-svc
h3=":443"; ma=86400
content-length
39791
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
cloudflare
etag
"9b6f-658841b5-ae7fd8136fe2636a;;;"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=DmHjRJFKl7jzN28fpwn9NuLbAe59alhioc5n2B32JizWdCA%2B1puBXsQfYxHEGPvL7hkwYSM5TvRouAtK4wktbSaSMDNv1yVplWnfnGsn7hycjJGP%2BfVz2r4Te%2FXHepH9ypBeo%2FNnCS3huNQgE%2F3Ixw%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type
image/jpeg
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
cf-ray
853ce7011f864d7c-FRA
expires
Fri, 16 Feb 2024 06:38:11 GMT
e-book-mabpurifications.png
biopharmaapac.com/webinar/whitepaper-purificationresin-16-6-2023/images/
2 MB
2 MB
Image
General
Full URL
https://biopharmaapac.com/webinar/whitepaper-purificationresin-16-6-2023/images/e-book-mabpurifications.png
Requested by
Host: www.biopharmaapac.com
URL: https://www.biopharmaapac.com/e-book-mabpurifications?__s=2220yg06mvnswjo9af2o&utm_source=drip&utm_medium=email&utm_campaign=Biocon+Biologics+Teams+Up+with+Sandoz+Australia+for+Biosimilar+Trastuzumab+and+Bevacizumab
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b2db57c90d966f5d0e0c90ef7d8ddfbbf1b443668402c9e1077475b13c69a579
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaapac.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Sun, 11 Feb 2024 13:22:44 GMT
content-security-policy
upgrade-insecure-requests
cf-cache-status
HIT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age
426191
alt-svc
h3=":443"; ma=86400
content-length
2481893
last-modified
Sun, 24 Dec 2023 14:35:38 GMT
server
cloudflare
etag
"25dee5-658841ba-d2c7b7ea53918a71;;;"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=1A3emlPhEK1q56FcfsHzvK0w1bFxC7QrIjlJJq3TITqcFnbkYlurTZEh9ah3l5d%2BX7pr2hXzF5Quj6OHuN4h6u8OY3giae0W%2Bg3CKwtUyiLwAJ%2B5vuRmjlXQL20VQyfctPx%2Fkoa%2BaufCf8NT%2FHHHrA%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type
image/png
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
cf-ray
853ce7011f8c4d7c-FRA
expires
Tue, 13 Feb 2024 14:59:33 GMT
e-book-mabpurifications-thumb.png
biopharmaapac.com/webinar/whitepaper-purificationresin-16-6-2023/images/
2 MB
2 MB
Image
General
Full URL
https://biopharmaapac.com/webinar/whitepaper-purificationresin-16-6-2023/images/e-book-mabpurifications-thumb.png
Requested by
Host: www.biopharmaapac.com
URL: https://www.biopharmaapac.com/e-book-mabpurifications?__s=2220yg06mvnswjo9af2o&utm_source=drip&utm_medium=email&utm_campaign=Biocon+Biologics+Teams+Up+with+Sandoz+Australia+for+Biosimilar+Trastuzumab+and+Bevacizumab
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
dcd1a76a6fda2fd770f975ef6357b6a03d25bfd90136cac68c5658f651a1985b
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaapac.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Sun, 11 Feb 2024 13:22:44 GMT
content-security-policy
upgrade-insecure-requests
cf-cache-status
HIT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age
188637
alt-svc
h3=":443"; ma=86400
content-length
1967585
last-modified
Sun, 24 Dec 2023 14:35:38 GMT
server
cloudflare
etag
"1e05e1-658841ba-7c9d6b684f0f65ac;;;"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=XHj7%2BHlq9afoEzyLSZVpv3dv%2BHvTbEUVVpLO5Y4DhIZ2lUtbxobaVSaQg05NqjNqwp8dzanq4e8f81Wsi%2FxeScZVh6Szw%2B%2B4UHdVg9n0%2FlXe4M8GeWpjBE4yn8DGlNg%2FI1ndSM74LaR3L8RyYiko0A%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type
image/png
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
cf-ray
853ce7011f834d7c-FRA
expires
Fri, 16 Feb 2024 08:58:47 GMT
email-decode.min.js
www.biopharmaapac.com/cdn-cgi/scripts/5c5dd728/cloudflare-static/
1 KB
1 KB
Script
General
Full URL
https://www.biopharmaapac.com/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js
Requested by
Host: www.biopharmaapac.com
URL: https://www.biopharmaapac.com/e-book-mabpurifications?__s=2220yg06mvnswjo9af2o&utm_source=drip&utm_medium=email&utm_campaign=Biocon+Biologics+Teams+Up+with+Sandoz+Australia+for+Biosimilar+Trastuzumab+and+Bevacizumab
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
2595496fe48df6fcf9b1bc57c29a744c121eb4dd11566466bc13d2e52e6bbcc8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaapac.com/e-book-mabpurifications?__s=2220yg06mvnswjo9af2o&utm_source=drip&utm_medium=email&utm_campaign=Biocon+Biologics+Teams+Up+with+Sandoz+Australia+for+Biosimilar+Trastuzumab+and+Bevacizumab
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Sun, 11 Feb 2024 13:22:43 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Wed, 07 Feb 2024 16:52:27 GMT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
etag
W/"65c3b54b-4d7"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=Y3fUCjloPIbgtcXJ7IVpOXWczcXTm92mb76AVRGclvUySepysxXuUmP%2BkK85Lrz0gEeL7I5kiEnH8DIHMuq5LPAdhER34hSocYO7QCVWWuyDvXaBF9nMRKTYoDrN8ZdoKL%2BNSANgvcfAqHJSIZC9NxLGo%2FU%3D"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
x-frame-options
DENY
cache-control
max-age=172800, public
cf-ray
853ce700ff514d7c-FRA
expires
Tue, 13 Feb 2024 13:22:43 GMT
jquery.min.js
cdnjs.cloudflare.com/ajax/libs/jquery/3.6.1/
88 KB
28 KB
Script
General
Full URL
https://cdnjs.cloudflare.com/ajax/libs/jquery/3.6.1/jquery.min.js
Requested by
Host: www.biopharmaapac.com
URL: https://www.biopharmaapac.com/e-book-mabpurifications?__s=2220yg06mvnswjo9af2o&utm_source=drip&utm_medium=email&utm_campaign=Biocon+Biologics+Teams+Up+with+Sandoz+Australia+for+Biosimilar+Trastuzumab+and+Bevacizumab
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6811:180e , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
a3cf00c109d907e543bc4f6dbc85eb31068f94515251347e9e57509b52ee3d74
Security Headers
Name Value
Strict-Transport-Security max-age=15780000
X-Content-Type-Options nosniff

Request headers

Referer
Origin
https://www.biopharmaapac.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Sun, 11 Feb 2024 13:22:44 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
strict-transport-security
max-age=15780000
age
5601664
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
content-length
27990
last-modified
Fri, 26 Aug 2022 18:34:13 GMT
server
cloudflare
cf-cdnjs-via
cfworker/kv
etag
"63091225-6d56"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=63qP7qw1naIk9ptjVsMXOe%2F4ok01fr%2BtrtShvcAT7uwnT8nAN%2FPd26zJ12L9UdpSq7%2B6x4UuepGNhf0sfluLNNsKdyF3Ad7hjPIyR8VDRB26BZlkt1Xegmoji600AIRUExvPgQP8iAlijn%2FDBVqeiFYj"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public, max-age=30672000
accept-ranges
bytes
timing-allow-origin
*
cf-ray
853ce7011fa04d32-FRA
expires
Fri, 31 Jan 2025 13:22:44 GMT
v84a3a4012de94ce1a686ba8c167c359c1696973893317
static.cloudflareinsights.com/beacon.min.js/
20 KB
7 KB
Script
General
Full URL
https://static.cloudflareinsights.com/beacon.min.js/v84a3a4012de94ce1a686ba8c167c359c1696973893317
Requested by
Host: www.biopharmaapac.com
URL: https://www.biopharmaapac.com/e-book-mabpurifications?__s=2220yg06mvnswjo9af2o&utm_source=drip&utm_medium=email&utm_campaign=Biocon+Biologics+Teams+Up+with+Sandoz+Australia+for+Biosimilar+Trastuzumab+and+Bevacizumab
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:3865 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
6153d13804862b0fc1c016cf1129f34cb7c6185f2cf4bf1a3a862eecdab50101

Request headers

Referer
https://www.biopharmaapac.com/
Origin
https://www.biopharmaapac.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36

Response headers

date
Sun, 11 Feb 2024 13:22:44 GMT
content-encoding
gzip
last-modified
Tue, 10 Oct 2023 21:38:13 GMT
server
cloudflare
etag
W/"2023.10.0"
vary
Accept-Encoding
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
cf-ray
853ce7011ba76977-FRA
rum
www.biopharmaapac.com/cdn-cgi/
0
181 B
XHR
General
Full URL
https://www.biopharmaapac.com/cdn-cgi/rum?
Requested by
Host: static.cloudflareinsights.com
URL: https://static.cloudflareinsights.com/beacon.min.js/v84a3a4012de94ce1a686ba8c167c359c1696973893317
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

Referer
https://www.biopharmaapac.com/e-book-mabpurifications?__s=2220yg06mvnswjo9af2o&utm_source=drip&utm_medium=email&utm_campaign=Biocon+Biologics+Teams+Up+with+Sandoz+Australia+for+Biosimilar+Trastuzumab+and+Bevacizumab
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/121.0.6167.160 Safari/537.36
content-type
application/json

Response headers

date
Sun, 11 Feb 2024 13:22:44 GMT
x-content-type-options
nosniff
server
cloudflare
vary
Origin
access-control-max-age
86400
access-control-allow-methods
POST,OPTIONS
access-control-allow-origin
https://www.biopharmaapac.com
x-frame-options
DENY
access-control-allow-credentials
true
cf-ray
853ce7021e0e4d37-FRA

Verdicts & Comments Add Verdict or Comment

4 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

function| $ function| jQuery function| validateForm object| __cfBeacon

1 Cookies

Domain/Path Name / Value
www.biopharmaapac.com/ Name: PHPSESSID
Value: h2h3kjqlh4cpr6tujmf468lbu0

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
Content-Security-Policy upgrade-insecure-requests